Could a diabetes drug help teens with rare obesity syndromes shed pounds?
Disease control
Recruiting now
This study tests tirzepatide, a weight loss medication, in 36 young adults aged 18-26 with obesity from Prader-Willi syndrome, hypothalamic obesity, or general causes. Participants take the drug for 48 weeks to see how much weight they lose and how their health changes. The goal …
Phase: PHASE4 • Sponsor: Grace Kim • Aim: Disease control
Last updated Jun 26, 2026 17:35 UTC